(Q73761848)
Statements
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril (English)
H R Black
A Graff
D Shute
R Stoltz
D Ruff
J Levine
Y Shi